AdvantiGen Biosciences, a start-up immunotherapy company, utilizes our patented technologies to create monoclonal antibodies (drugs) for the treatment of cancer and other diseases. We’re developing a new drug to a previously unknown cancer target. This new Immune Checkpoint Inhibitor drug has the potential to reach Billions in annual sales. Our team has decades of experience
RoddyMedical designs, develops and commercializes innovative, proprietary medical devices, focusing on improving clinical and patient safety. These devices are inspired by the firsthand experiences of those on the frontlines of healthcare.
PersoDX, Inc. is a Wisconsin based precision medicine company dedicated to finding new ways to optimize health on an individual level. We are developing a first-in-class diagnostic product called HepSight, which helps clinicians optimize drug selection, dosing, and safety. PersoDX’s founder, Dr. Joseph McGraw, is a pharmacist, professor, and scientist with over 20 years of
Elephas is building an instrument platform that will inform how clinicians treat cancer patients. The platform will interrogate live human tumors ex vivo. While the system is being designed to help determine the best cancer therapy for each patient, there will be significant potential applications of the platform for biopharma companies developing oncology drugs and
Developing novel discovery processes for biologically active organisms from the soil.